Furthermore, elevated TRIM46 expression in advanced ovarian cancer patients and its association with poor prognosis suggest that TRIM46 could serve as both a prognostic biomarker and a therapeutic target. The gene discussed is TRIM46; the disease is ovarian carcinoma.